However, it has been demonstrated that this variant is not associated with venous thrombosis risk in the heterozygous state
Emerging data also point to benefits in conditions such as obstructive sleep apnea (OSA) and chronic kidney disease, including tirzepatide for moderate-to-severe OSA in adults with obesity and semaglutide for reducing kidney and cardiovascular risk in adults with CKD and T2D
DUAL V Investigators
Court Decision Prevents Compounders from Producing Knockoffs of Novo Nordisks Semaglutide Grand View Research, UK GLP-1 Receptor Agonist Market Harvard University, GLP-1 Diabetes and Weight Loss Drug Side Effects: Ozempic Face and More Diabetes.org, How Many People in the UK Have Diabetes? CDC, National Diabetes Statistics Report WHO, Obesity and Overweight Health.com, Think GLP-1s Guarantee Weight Loss
The program demonstrated biological activity but also identified cardiovascular effects that influenced development strategy
This started working from Day 1 and curved my appetite